The quality of surgical pathology care for men undergoing radical prostatectomy in the U.S.

Cancer

Volumn 109, Issue 12, 2007, Pages 2445-2453

  Miller, David C ^a   Spencer, Benjamin A ^b   Shah, Rajal B ^c   Ritchey, Jamie ^d   Stewart, Andrew K ^d   Gay, E Greer ^d   Dunn, Rodney L ^c   Wei, John T ^c   Litwin, Mark S ^a,e,f  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b College of Physicians and Surgeons ^*  (United States)

^c UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^d AMERICAN COLLEGE OF SURGEONS   (United States)

^e UNIVERSITY OF CALIFORNIA   (United States)

^f UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Pathology; Prostate cancer; Quality; Radical prostatectomy

Indexed keywords

ADULT; AGED; ARTICLE; CANCER INVASION; CANCER STAGING; CLINICAL PROTOCOL; GLEASON SCORE; HEALTH CARE QUALITY; HUMAN; HUMAN TISSUE; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; MEDICAL SOCIETY; METASTASIS; PATHOLOGY; PRIORITY JOURNAL; PROGNOSIS; PROSTATE CANCER; PROSTATECTOMY; SEMINAL VESICLE; TUMOR LOCALIZATION; TUMOR VOLUME;

AGED; GUIDELINE ADHERENCE; HUMANS; MALE; MIDDLE AGED; NEOPLASM STAGING; PATHOLOGY, SURGICAL; PHYSICIAN'S PRACTICE PATTERNS; PROSTATE-SPECIFIC ANTIGEN; PROSTATECTOMY; PROSTATIC NEOPLASMS; QUALITY INDICATORS, HEALTH CARE; UNITED STATES;

EID: 34250169034     PISSN: 0008543X     EISSN: 10970142     Source Type: Journal    
DOI: 10.1002/cncr.22698     Document Type: Article

References (38)

1. Compton CC. Surgical pathology for the oncology patient in the age of standardization: of margins, micrometastasis, and molecular markers. Semin Radiat Oncol. 2003;13:382-388.
2. Srigley JR. Key issues in handling and reporting radical prostatectomy specimens. Arch Pathol Lab Med. 2006;130: 303-317.
3. Srigley JR, Amin MB, Bostwick DG, et al. Updated protocol for the examination of specimens from patients with carcinomas of the prostate gland: a basis for checklists. Cancer Committee. Arch Pathol Lab Med. 2000;124:1034-1039.
4. Henson DE, Hutter RV, Farrow G. Practice protocol for the examination of specimens removed from patients with carcinoma of the prostate gland. A publication of the Cancer Committee, College of American Pathologists. Task Force on the Examination of Specimens Removed From Patients With Prostate Cancer. Arch Pathol Lab Med. 1994;118:779-783.
5. Amin MB. Key issues in reporting common cancer specimen findings using the College of American Pathologists cancer protocols. Arch Pathol Lab Med. 2006;130:284-286.
6. Institute of Medicine. Assessing the Quality of Cancer Care: An Approach to Measurement in Georgia. Washington, DC: The National Academies Press; 2005.
7. Litwin MS, Steinberg M, Malin JL, et al. Prostate Cancer Patient Outcomes and Choice of Providers: Development of an Infrastructure for Quality Assessment. Santa Monica, Calif: RAND; 2000.
8. Miller DC, Litwin MS, Sanda MG, et al. Use of quality indicators to evaluate the care of patients with localized prostate carcinoma. Cancer. 2003;97:1428-1435.
9. Spencer BA, Steinberg M, Malin J, Adams J, Litwin MS. Quality-of-care indicators for early-stage prostate cancer. J Clin Oncol. 2003;21:1928-1936.
10. Miller DC, Montie JE, Wei JT. Measuring the quality of care for localized prostate cancer. J Urol. 2005;174:425-431.
11. American College of Surgeons Commission on Cancer. What is the NCDB? Available at URL: http://www.facs.org/cancer/ncdb/ncdbabout.html Accessed October 30, 2006.
12. Mettlin CJ, Menck HR, Winchester DP, Murphy GP. A comparison of breast, colorectal, lung, and prostate cancers reported to the National Cancer Data Base and the Surveillance, Epidemiology, and End Results Program. Cancer. 1997;79:2052-2061.
13. American College of Surgeons Commission on Cancer. Categories of approval. Available at URL: http://www.facs.org/cancer/coc/categories.html#3. Accessed October 30, 2006.
14. Spencer BA, Steinberg M, Malin J, Adams J, Setodji C, Litwin MS. Quality-of-care indicators for early-stage prostate cancer [abstract]. J Urol. 2005;173(s):51.
15. Srigley JR, Amin MB, Humphrey PA, for Members of the Cancer Committee College of American Pathologists. College of American Pathologists. Prostate gland checklist. Available at URL: http://www.cap.org/apps/docs/ cancer_protocols/2005/prostate05_ckw.pdf. Accessed October 30, 2006.
16. Imperato PJ, Waisman J, Nenner RP. Radical prostatectomy specimens among Medicare patients in New York State: a review of pathologists' reports. Arch Pathol Lab Med. 1998; 122:966-971.
17. Imperato PJ, Waisman J, Wallen M, et al. The use of quality indicators for assessing radical prostatectomy specimens. Am J Med Qual. 2000;15:212-220.
18. Nolan T, Berwick DM. All-or-none measurement raises the bar on performance. JAMA. 2006;295:1168-1170.
19. Centers for Medicare and Medicaid Services.Eighth scope of work. Available at URL: http://www.cms.hhs.gov/qualityimprovementorgs/downloads/ 8thsow.pdf. Accessed January 3, 2007.
20. Institute of Medicine. Performance Measurement: Accelerating Improvement. Washington, DC: The National Academies Press; 2006.
21. Malin JL, Schneider EC, Epstein AM, Adams J, Emanuel EJ, Kahn KL. Results of the National Initiative for Cancer Care Quality: how can we improve the quality of cancer care in the United States? J Clin Oncol. 2006;24:626-634.
22. Imperato PJ, Waisman J, Wallen M, et al. Results of a cooperative educational program to improve prostate pathology reports among patients undergoing radical prostatectomy. J Community Health. 2002;27:1-13.
23. Bull AD, Biffin AH, Mella J, et al. Colorectal cancer pathology reporting: a regional audit. J Clin Pathol. 1997;50:138-142.
24. Kawakami J, Meng MV, Sadetsky N, Latini DM, Duchane J, Carroll PR. Changing patterns of pelvic lymphadenectomy for prostate cancer: results from CaPSURE. J Urol. 2006; 176:1382-1386.
25. Greene FL, Brierley J, O'Sullivan B, Sobin LH, Wittekind C. On the use and abuse of X in the TNM classification. Cancer. 2005;103:647-649.
26. Greene FL. TNM: our language of cancer. CA Cancer J Clin. 2004;54:129-130.
27. Stephenson AJ, Shariat SF, Zelefsky MJ, et al. Salvage radiotherapy for recurrent prostate cancer after radical prostatectomy. JAMA. 2004;291:1325-1332.
28. Kibel AS. An interdisciplinary approach to treating prostate cancer. Urology. 2005;65(6 suppl):13-18.
29. Greene FL, Page DL, Fleming ID, et al., eds., AJCC Cancer Staging Manual. 6th ed. New York, NY: Springer-Verlag; 2002.
30. American College of Surgeons Commission on Cancer. Cancer program standards. Available at URL: http://www.facs.org/cancer/coc/cocprogramstandards. pdf Accessed October 30, 2006.
31. Montironi R, van der KT, Boccon-Gibod L, Bono AV, Boccon-Gibod L. Handling and pathology reporting of radical prostatectomy specimens. Eur Urol. 2003;44:626-636.
32. Compton CC. Key issues in reporting common cancer specimens: problems in pathologic staging of colon cancer. Arch Pathol Lab Med. 2006;130:318-324.
33. Tobias J, Chilukuri R, Komatsoulis GA, et al. The CAP cancer protocols - a case study of caCORE based data standards implementation to integrate with the Cancer Biomedical Informatics Grid. BMC Med Inform Decis Mak. 2006;6:25.
34. Dresselhaus TR, Peabody JW, Lee M, Wang MM, Luck J. Measuring compliance with preventive care guidelines: standardized patients, clinical vignettes, and the medical record. J Gen Intern Med. 2000;15:782-788.
35. Luck J, Peabody JW, Dresselhaus TR, Lee M, Glassman P. How well does chart abstraction measure quality? A prospective comparison of standardized patients with the medical record. Am J Med. 2000;108:642-649.
36. Peabody JW, Luck J, Glassman P, Dresselhaus TR, Lee M. Comparison of vignettes, standardized patients, and chart abstraction: a prospective validation study of 3 methods for measuring quality. JAMA. 2000;283:1715-1722.
37. Bostwick DG, Montironi R. Evaluating radical prostatectomy specimens: therapeutic and prognostic importance. Virchows Arch. 1997;430:1-16.
38. Soloway MS, Pareek K, Sharifi R, et al. Neoadjuvant androgen ablation before radical prostatectomy in cT2bNxM0 prostate cancer: 5-year results. J Urol. 2002;167:112-116.